Are the recommendations for the use of anti-TNF drugs during axial spondyloarthritis relevant for non-radiographic forms?

Joint Bone Spine. 2020 Oct;87(5):381-383. doi: 10.1016/j.jbspin.2020.02.007. Epub 2020 Mar 5.

Authors

Philippe Goupille¹, Daniel Wendling²

Affiliations

¹ Service de Rhumatologie, CHRU de Tours, EA 7501, GICC, Université de Tours, Tours, France. Electronic address: goupille@med.univ-tours.fr.
² Service de Rhumatologie, CHRU de Besançon, EA 4266, Université de Franche-Comté, Besançon, France.

PMID: 32147568
DOI: 10.1016/j.jbspin.2020.02.007

No abstract available

Keywords: Axial spondyloarthritis; Biomedication; NSAIDs; Recommendations; Treatment.

Publication types

Editorial

MeSH terms

Humans
Pharmaceutical Preparations*
Spondylarthritis* / diagnostic imaging
Spondylarthritis* / drug therapy
Spondylitis, Ankylosing*
Tumor Necrosis Factor Inhibitors

Substances

Pharmaceutical Preparations
Tumor Necrosis Factor Inhibitors